Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Shteinberg

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
ERJ Open Research|January 16, 2024
<i>Mycobacterium avium</i> complex pulmonary disease patients with limited treatment optionsStefano Aliberti, Francesco Blasi, Pierre-Régis Burgel, et al.
The European Respiratory Journal|June 29, 2023
Transforming clinical research and science in bronchiectasis: EMBARC3, a European Respiratory Society Clinical Research CollaborationJames D Chalmers, Stefano Aliberti, Josje Altenburg, et al.
The European Respiratory Journal|March 11, 2021
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guidelineJames D Chalmers, Megan L Crichton, Pieter C Goeminne, et al.
The European Respiratory Journal|June 16, 2022
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guidelineNicolas Roche, Megan L Crichton, Pieter C Goeminne, et al.
American Journal of Respiratory and Critical Care Medicine|January 20, 2022
Characterization of Eosinophilic Bronchiectasis: A European Multicohort StudyAmelia Shoemark, Michal Shteinberg, Anthony De Soyza, et al.
Annals of the American Thoracic Society|January 28, 2021
Thrombocytosis during Stable State Predicts Mortality in BronchiectasisStefano Aliberti, Giovanni Sotgiu, Andrea Gramegna, et al.
The New England Journal of Medicine|April 23, 2025
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in BronchiectasisJames D Chalmers, Pierre-Régis Burgel, Charles L Daley, et al.
The European Respiratory Journal|May 29, 2024
Airway IL-1β is related to disease severity and mucociliary function in bronchiectasisLidia Perea, Mathieu Bottier, Erin Cant, et al.
Annals of the American Thoracic Society|January 9, 2024
Bronchiectasis with Chronic Rhinosinusitis Is Associated with Eosinophilic Airway Inflammation and Is Distinct from AsthmaMichal Shteinberg, James D Chalmers, Jayanth K Narayana, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 18, 2023
Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutationIdo Sadras, Eitan Kerem, Galit Livnat, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
ERJ Open Research|January 16, 2024
<i>Mycobacterium avium</i> complex pulmonary disease patients with limited treatment optionsStefano Aliberti, Francesco Blasi, Pierre-Régis Burgel, et al.
The European Respiratory Journal|June 29, 2023
Transforming clinical research and science in bronchiectasis: EMBARC3, a European Respiratory Society Clinical Research CollaborationJames D Chalmers, Stefano Aliberti, Josje Altenburg, et al.
The European Respiratory Journal|March 11, 2021
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guidelineJames D Chalmers, Megan L Crichton, Pieter C Goeminne, et al.
The European Respiratory Journal|June 16, 2022
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guidelineNicolas Roche, Megan L Crichton, Pieter C Goeminne, et al.
American Journal of Respiratory and Critical Care Medicine|January 20, 2022
Characterization of Eosinophilic Bronchiectasis: A European Multicohort StudyAmelia Shoemark, Michal Shteinberg, Anthony De Soyza, et al.
Annals of the American Thoracic Society|January 28, 2021
Thrombocytosis during Stable State Predicts Mortality in BronchiectasisStefano Aliberti, Giovanni Sotgiu, Andrea Gramegna, et al.
The New England Journal of Medicine|April 23, 2025
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in BronchiectasisJames D Chalmers, Pierre-Régis Burgel, Charles L Daley, et al.
The European Respiratory Journal|May 29, 2024
Airway IL-1β is related to disease severity and mucociliary function in bronchiectasisLidia Perea, Mathieu Bottier, Erin Cant, et al.
Annals of the American Thoracic Society|January 9, 2024
Bronchiectasis with Chronic Rhinosinusitis Is Associated with Eosinophilic Airway Inflammation and Is Distinct from AsthmaMichal Shteinberg, James D Chalmers, Jayanth K Narayana, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 18, 2023
Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutationIdo Sadras, Eitan Kerem, Galit Livnat, et al.
Pageof 15